

お知らせ
-
2025.03.11中村英樹、秋谷久美子、大島美穂、北村 登話題 シェーグレン症候群に対する分子標的治療リウマチ科. 73 (2): 197-205, 2025
-
2025.02.20
北村 登
解説 リウマチ性疾患の難治性病態における血液疾患の関与.
リウマチ科. 73(1): 110-115, 2025.
-
2025.01.15
Horai Y, Kurushima S, Shimizu T, Nakamura H, Kawakami A.
Do coexistence of Sjögren’s syndrome and/or presence of anti-Ro/SS-A antibodies influence therapeutic strategies for rheumatoid arthritis? in the light of effectiveness, and risk of lymphoproliferative disease.
Journal of Clinical Medicine
(IF3.0)
-
2024.12.11
Nagata K, Tsukamoto M, Nagasawa Y, Kitamura N, Nakamura H.
Direct inhibitory effect of HTLV-1-infected T cells on the production of anti-Ro/SS-A antibody by B cells from patients with Sjögren’s syndrome.
European Journal of Immunology (IF 4.5)
-
2024.11.07
Horai Y, Shimizu T, Nakamura H, Kawakami A.
Recent Advances in pathogenesis, diagnostic imaging, and treatment of
Sjögren’s syndrome.
Journal of Clinical Medicine (IF: 3.0) -
2024.10.12
Nishihara M, Nagae A, Otake S, Asatani S, Nagasawa Y, Akiya K, Inomata H, Kitamura N, Nakamura H.
Successful treatment for a patient with antiphospholipid syndrome and decreased protein S activity exacerbated by heparin-induced thrombocytopenia: A Case Report
Medicine (IF1.60)
-
2024.10.11
Kobashi Y, Suzuki H, Nakagawa M, Kojima T, Tsujimura R, Miura K, Nakamura H, Okada M
Osteosclerosing multiple myeloma:A case highlighting critical value of image findings for the diagnosis
Radiology Case Reports
-
2024.10.09
Nakamura H, Tsukamoto M, Nagata K, Nagasawa Y, Akiya K, Inomata H, Nishihara M, Asatani S, Kitamura N, Kitano H, Shoji J, Iwabuchi Y, Ishige T, Hao H.
Sjögren’s syndrome positive for isolated anti-Ro52/SS-A antibody and anti-centromere antibody
Journal of International Medical Research (IF1.40) -
2024.08.06
Akiya K, Nishihara M, Nagasawa Y, Kitamura N, Kitano H, Shoji J, Iwabuchi Y, Hao H,Nakamura H.
Subjective symptoms and disease activity related to serum zinc concentration in primary Sjögren’s syndrome.
Journal of Clinical Medicine (IF3.0)